It in turn uses these company assets to turnover higher revenue. Also known as the payables turnover ratio or creditors turnover ratio, this liquidity ratio measures the number of times a company pays its creditors over an accounting period. Kpmg Sponsored Degree, Current Industry PE. Please check your download folder. 1. 2 While the pandemic has created opportunities for the biopharma industry to demonstrate the industrys value, it also has led to potential short- If this is the case, the company has more than enough cash to meet its liabilities while using its capital effectively. ideal current ratio for pharmaceutical industry. Share Price 965.2: Mar 02,2023 . | liability for the information given being complete or correct. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. 4 Return on Equity. To make informed choices, investors need to consider the key financial ratios that are most helpful in the analysis and equity evaluation of pharma firms. Ratio: Debt-to-equity ratio Measure of center: The efficiency and turnover measures the ability of the company to manage its assets and liabilities efficiently for the company. Get Standard Medical Pharmaceuticals latest Key Financial Ratios, Financial Statements and Standard Medical Pharmaceuticals detailed profit and loss accounts. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". Net credit purchases may be substituted at times by COGS and, Average accounts payable = sum of accounts payable at the beginning and end of accounting period / 2. This measures the companys ability to meet its short-terms obligations using its liquid assets (that can be quickly converted to cash). Share Price 966.8: Mar 03,2023 . Teva Pharmaceutical Industries current ratio for the three months ending March 31, 2022 was 1.07. Built using WordPress and the Highlight Theme. Financial ratios serve as an important tracking tool for identifying trends and discrepancies in the companys finances. Our expert team of analysts at Eqvista can support you through this process. The Current P/E Ratio of SUN PHARMACEUTICAL INDUSTRIES is 54.30. All companies haven't been maintaining ideal current ratio except Sunpharma. Emerging markets include middle and lower-income countries, including Brazil, India, Russia, Colombia, Egypt, and Russia. Roche was established in 1896. Are you interested in testing our business solutions? If you want to start issuing and managing shares, Try out our Eqvista App, it is free and all online! Browse . Search Stocks. The best way to use this ratio is to compare the companys present ratio to its historical ratio as well as the one of competitors and industry average. With the flattening of growth in pharma sales in developed countries, drug makers are increasingly looking to emerging markets for new sources of growth and revenue. Statista assumes no Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Market forecast and expert KPIs for 600+ segments in 150+ countries, Insights on consumer attitudes and behavior worldwide, Business information on 60m+ public and private companies, Detailed information for 35,000+ online stores and marketplaces. Company Valuation The quick ratio. Calculation: Current Assets / Current Liabilities. Explore now . Life expectancy and health outcomes have seen tremendous improvements in the last 100 years. We are happy to help. It helps identify the companies in a business with the best practices of using their assets in comparison to their earnings. Inventories are those goods in stock of a company that it plans to sell. A higher than industry average current ratio indicates that the company has a considerable size of short-term assets value in comparison to their short-term liabilities. With revenue increase of 4.27% in 4 Q 2022 year on year, revenue per employee for Biotechnology & Pharmaceuticals Industry grew on trailing twelve months basis to 997,180 $, above Biotechnology & Pharmaceuticals Industry average. Novo Nordisk's gross margin in that year was 82 . 2023Gospel Vision. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Do you want to find out the Price to Earnings (PE) ratio history of SUN PHARMACEUTICAL INDUSTRIES and compare it with industry peers of SUN PHARMACEUTICAL INDUSTRIES . Within Healthcare sector 4 other industries have achieved higher Working Capital Ratio. Note, Numbers include only companies who have reported earnings results. This is one reason why it is also important to consider a pharma company's debt and liquidity situation. A higher FAT ratio indicates that the management has efficiently used its fixed assets to generate revenue for the company while a lower FAT ratio points at the opposite. It is safe to expect the same line of growth from these markets for the next few years. The return on total assets (ROTA) ratio measures how efficiently a company is generating income using its assets. . Explore now . The price-to-research ratio measures the relationship between a company's market capitalization and its research and development expenses. The price-to-research ratio is calculated by dividing a company's market value by its last 12 months of expenditures on research and development. Determining the optimal one for your company will depend on factors such as the type of business, its age, and the stage of the business cycle. This ratio is an important determiner of pricing, manufacturing, marketing, and purchasing decisions. Working Capital Ratio total ranking has deteriorated relative to the New CE data from 20092010 will become. By 2025, the market is estimated to have a CAGR of 8%, reaching $1700.97 billion. Do you want to find out the Price to Sales (PS) ratio history of SUN PHARMACEUTICAL INDUSTRIES and compare it with industry peers of SUN PHARMACEUTICAL INDUSTRIES . Staying up-to-date with the latest information. Once a pharmaceutical company manages to bring a product to market, a key element is how the company can manufacture and sell the product. Cipla has showed highest current ratio in 2012. Generate on-demand reports for any company for any given period. Because R&D expenses are a major cost for pharmaceutical companies, one of the key financial metrics for analyzing pharma companies is a ratio that indicates the financial return a company realizes from its R&D expenditures. Key financial ratios for pharmaceutical companies are those related to R&D costs and the company's ability to manage high levels of debt and profitability. It is up to a financial analyst to use trend analysis, common size analysis, and ratio analysis to compare the subject company and the selected benchmarks in order to create a reliable multiple. Explore now . Around 15% of the total market supply of pharmaceuticals is produced in domestic markets. Among top pharmaceutical companies in 2021, Novo Nordisk had the highest gross margin, followed by Biogen and Gilead Sciences. Clicking on the following button will update the content below. The debt ratio measures the amount of leverage that a company has and indicates the proportional amount of a companys assets that are financed through debt. Check your inbox or spam folder to confirm your subscription. Quick Ratio total ranking fell in contrast to the previous quarter from to 12. Teva acquired Allergan's generics business Actavis Generics. North America is projected to grow at a CAGR between 4.2 and 4.2 percent over the same period. This ratio will vary with industry based on the measure of their fixed assets. All companies havent been maintaining ideal current ratio except Sunpharma. With so much capital at stake, as well as the rapid pace of technological disruption, put more focus on prevention, digital health, and healthcare. 71. That being said, how good a current ratio is depends on the type of company youre talking about. Teva Pharmaceutical Industries current ratio for the three months ending December 31, 2022 was 1.05. Financial Ratio It includes chemical study and regulation. The return-on-equity ratio (ROE) is considered a key ratio in equity evaluation because it addresses a question of prime importance to investors, which is what kind of return the company is generating in relation to its equity. El Paso Saddlery Military, Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features. Pfizer had annual revenues of USD 81.28 billion in 2021, and was the 3rd ranked pharmacy company in terms of revenue for the last 4 years, just behind Roche and Johnson & Johnson. Pharmaceutical Preparations: average industry financial ratios for U.S. listed companies Industry: 2834 - Pharmaceutical Preparations Measure of center: median (recommended) average Financial ratio Top 10 Pharma Trends in 2022 1. 71. Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically. The cookies is used to store the user consent for the cookies in the category "Necessary". Key financial ratios for pharmaceutical companies are those related to R&D costs and the company's ability to manage high levels of debtand profitability. New York City, NY 10170. Ranking, Inventory Turnover (Sales) These include financial and ethical ones. It controls many of the worlds largest pharmaceutical companies, including Genentech (USA), Chugai Pharmaceuticals (Japan), and Ventana (USA). Browse . The inventory turnover ratio provides a snapshot about the companys stock management and whether the sales and purchasing department are working in sync. Because pharmaceutical companies must make large capital expenditures on R&D, they must be able to maintain adequate levels of liquidity and effectively manage their characteristically high levels of debt. Higher the asset turnover ratio, better the companys performance as it indicates that the company is generating substantial revenue based on its assets. 05.10.2017. For the Year ended 2019: Current Assets = Cash and Cash Equivalents + Marketable Securities + Accounts Receivable. Browse . 420 Lexington Avenue, Suite 300 Brazil was the South American country with the largest pharmaceutical market value at nearly 21 Billion U.S. dollars in 2020. Ideal Inventory Turnover Ratio. .a{fill:#6db41e;stroke:#637733;}.b,.d{fill:none;}.b{stroke:#fff;}.c{stroke:none;}, +899.62 (+1.53%) A higher inventory turnover ratio is ideal as it indicates that sales are quick and there is a demand for the companys products as well. Dollars)","floating":false,"align":"center"},"series":[{"type":"","name":"Sales (In Million USD)","color":"","label":"Sales (In Million USD)","orig_header":"salesinmillionusd","data":[36900,20700,17700,17200,12800,10800,9100,8600,7600,6500],"yAxis":0}],"xAxis":{"categories":["Comirnaty (BioNTech\/Pfizer)","Humira (AbbVie)","Spikevax (Moderna)","Keytruda (Merck & Co.)","Revlimid (BMS)","Eliquis (BMS)","Stelara (Janssen Biotech)","Biktarvy (Gilead)","Opdivo (BMS\/Ono Pharm. Company Name, Ticker, Competitors, else.. Net Income/Employee Analytical cookies are used to understand how visitors interact with the website. ideal current ratio for pharmaceutical industry. We will be pleased to help you in dealing with all the aspects of your business. This report advises NVS to pursue more market acquisition strategies in emerging markets. The curation of data over 10 years makes it a go-to document for in-depth industry trends. if(typeof(wpDataCharts)=='undefined'){wpDataCharts = {};}; wpDataCharts[525] = {render_data: {"options":{"title":{"text":"World Pharmaceutical Market Growth By Region 2021-2025","floating":false,"align":"center"},"series":[{"type":"","name":"Region","color":"","label":"Region","orig_header":"marketgrowthin","data":[12.6,10.9,8.6,6.7,5.7,4.9,4.5,4.5,4.3,4.2,2.8,-0.3],"yAxis":0}],"xAxis":{"categories":["Latin America","Indian subcontinent","Commonwealth of Independent States","Europe non-EU (incl. Where according to the companys balance sheets: To interpret the current ratio of a company, it has to be measured against industry standards. Do you want to find out the Price to Earnings (PE) ratio history of SUN PHARMACEUTICAL INDUSTRIES and compare it with industry peers of SUN PHARMACEUTICAL INDUSTRIES . Reproduction of news articles, photos, videos or any other content in whole or in part in any form
Please do not hesitate to contact me. Miscellaneous Fabricated Products Industry, Industrial Machinery and Components Industry, Renewable Energy Services & Equipment Industry, Miscellaneous Financial Services Industry, Major Pharmaceutical Preparations Industry, Laboratory Analytical Instruments Industry, In Vitro & In Vivo Diagnostic Substances Industry, Print Media & Newspaper Publishing Industry, Computer Peripherals & Office Equipment Industry, Internet Services & Social Media Industry, Electronic Instruments & Controls Industry, Computer processing and cloud services Industry, Scientific & Technical Instruments Industry, Internet, Mail Order & Online Shops Industry, Pharmacy Services & Retail Drugstore Industry, More Major Pharmaceutical Preparations Industry historic financial strength information >>, Compare Industry's quick ratio to Wkhs's or S&P, Constituent list of Major Pharmaceutical Preparations Industry. Similar to FAT, asset turnover ratio will also vary with industry. Current Assets = 36,092 + 18,929 + 20,816 = $ 75,837 (in millions) Current Liabilities = $ 87,812 (in millions) Quick Ratio = Current Assets / Current Liabilities. Pfizer was however back in the first place due to record-breaking COVID-19 sales. % Off. Home > PE Ratio > SUN PHARMACEUTICAL INDUSTRIES . This ratio is also frequently used in financial modeling as an important assumption for balance sheet forecast. The return on research capital ratio (RORC) is a fundamental measure that reveals the gross profit that a company realizes from each dollar of R&D expenditures. It gives a futuristic estimate of what the future earnings might look like. Current and historical current ratio for Pfizer (PFE) from 2010 to 2022. The United States was the largest single pharmaceutical market in 2021, with more than 550 billion U.S. Key financial ratios for pharmaceutical companies are those related to R&D costs and the company's ability to manage high levels of debt and profitability. by Sarath A company's ROE is a valuable indicator of both how effectively the organization is utilizing its equity capital and how profitable the company is for equity investors. We are happy to help you with everything and also offer free training. Current ratio = current assets/current liabilities Where according to the company's balance sheets: Current assets: cash, accounts receivable, inventory, and other assets that the company plans to liquidate or convert to cash within the next one year. This ratio is used to assess the firms ability to meet its short term liabilities on time. For most industries, the ideal inventory turnover ratio will be between 5 and 10, meaning the company will sell and restock inventory roughly every one to two . Humira was the second-ranked drug in 2021 with nearly 21 billion dollars in revenue. The scope of growth in the mutual fund investment space is immense in . The cookie is used to store the user consent for the cookies in the category "Analytics". Pharmaceutical companies have been top performers in the healthcare sector in an era of aging populations, rising healthcare costs, and the ongoing development of new and extremely profitable medicines. Best Restaurants In Chester, Va, Due to varying update cycles, statistics can display more up-to-date This website uses cookies to improve your experience while you navigate through the website. Normally, the size of a firm is measured by applying the three approaches i.e.. However, if the fall in the current ratio below 1.00 is temporary due to the allocation of short-term cash resources for expansion of capacity or scaling up of business, there is nothing to worry about. french open tsitsipas woolworths shareholder equity. Quick Ratio This ratio is sometimes known as Acid Test or Liquidity Ratio.lt is the Relation between quick asset In this article, we will explore the idea of financial ratios with a deeper insight into some of the basic types of ratios. The annual growth rate has a CAGR of 1.8%. Within Healthcare sector only one Industry has accomplished higher Quick Ratio. Share Price 965.2: Mar 02,2023: Market Cap 231,580.4 Cr: Book Value . One of the leading players in the industry, Johnson & Johnson, has reported sales of $23.3bn in the third quarter of 2021, a rise of 10.7% compared to $21.08bn in the same quarter in 2020. The latest update on challenges and trends in the pharmaceutical industry is already available: 2021 Challenges and Trends in Pharmaceutical Industry The pharmaceutical manufacturing industry is the one that is growing day by day due to the ever-increasing demand in its services. irritability crossword clue. Financial Statement and Ratio Analysis Liquidity GSK MRK NVS Industry Average Current Ratio 1.1X 2.1X 1.2X 1.7X Quick Ratio 0.7X 1.4X 0.7X 1.2X ! Today, its headquarters are located in Basel. In the kingdom, there are about 15-20 pharmaceutical manufacturers, which include local companies and subsidiaries of multinational pharmaceutical companies. Number of U.S. listed companies included in the calculation: 4190 (year 2021). Hold Indoco Remedies; target of Rs 250: ICICI Direct. Population aging, pricing pressures and greater expectations from more people The industry is trading close to its 3-year average PS ratio of 4.3x. This statistic provides information on the expected global growth of the pharmaceutical market between 2021 and 2025. Essay, Pages 8 (1901 words) Views. Buy Natco Pharma; target of This price to earnings ratio compares current earnings to future earnings. Effectiveness Performance Major Pharmaceutical Preparations Industry Efficiency Information & Trends These cookies track visitors across websites and collect information to provide customized ads. Artificial Intelligence. Lincoln Pharmaceuticals 5. It is in favor of the company to be in a comfortable cash flow scenario. However the ratio will eventually depend on the terms set by the suppliers based on their relationship with the company and their bargaining power. Return On Tangible Equity. The pharmaceutical industry creates 1.7 new jobs for every job. Europes top high-tech industry employers are the research-based pharmaceutical industries. This statistic lists the global pharmaceutical sales between 2010 and 2021. Do you want to find out the Price to Earnings (PE) ratio history of SUN PHARMACEUTICAL INDUSTRIES and compare it with industry peers of SUN PHARMACEUTICAL INDUSTRIES . The cookie is used to store the user consent for the cookies in the category "Other. Research firm MarketsandMarkets predicts that the global active pharmaceutical ingredient (API) market including chemical and biologic drug substances, both branded and generic will expand at a compound annual growth rate (CAGR) of 6.3%, and will climb from $157.95 billion in 2016 to $213.97 billion in 2021 (6). This ratio also helps to compare various companies in the same sector. transverse baby 28 weeks uncomfortable. Numbers change as more businesses report financial results. Out stock . Copyright e-Eighteen.com Ltd. All rights reserved. Industry benchmarks are either derived from these company-driven multiples or from credible industry benchmark databases. The main aim is achieved through ratio analysis of two pharmaceutical (Beximco and Square pharmaceutical) companies in Bangladesh. More about debt-to-equity ratio. SADIF Investment Analytics - Research Reports, Online Platform with financial daily data. This is an important industry benchmark to show how much the company compensates the officers when compared to its competitors. In general, a current ratio between 1.5 to 2 is considered beneficial for the business, meaning that the company has substantially more financial resources to cover its short-term debt and that it currently operates in stable financial solvency. A lower ratio indicates the contrary. The current ratio measures a company's capacity to pay its short-term liabilities due in one year. ROI. In general, a good current ratio is anything over 1, with 1.5 to 2 being the ideal. What is the Ideal Current Ratio? Current ratio, otherwise known as the working capital ratio, is a form of liquidity ratio that indicates a companys ability to pay back short-term obligations or the ones due within the next year. Pharmaceutical Preparations: average industry financial ratios for U.S. listed companies Industry: 2834 - Pharmaceutical Preparations Measure of center: median (recommended) average Financial ratio Teva Pharmaceutical Industries current ratio for the three months ending December 31, 2022 was. Therefore, it is also helpful for investors to look at basic profitability ratios, such as operating margin and net margin. They also need to work with regulatory agencies to ensure that this is safe for patients. Quick Ratio This ratio is sometimes known as Acid Test or Liquidity Ratio.lt is 1 Return on Research Capital Ratio. Despite being the leading COVID-19 vaccine manufacturer in North America, Pfizer slid in the rankings to third place. Key ratios are the main mathematical ratios that illustrate and summarize the current financial condition of a company. Pfizer current ratio for the three months ending December 31, 2022 was . The Current P/E Ratio of SUN PHARMACEUTICAL INDUSTRIES is 53.67. Operating margin, the basic measure of revenues minus production costs, indicates how well the company manages costs, and net margin is the bottom line indicator of profit realized after deducting all of a company's expenses, including taxes and interest. As we observed in the previous section, the IRS financial ratio database is the most reliable reference point. These cookies will be stored in your browser only with your consent. Also known as the times-interest-earned ratio, this is used by lenders, creditors, and investors to gauge the risk factor involved in lending capital to the company. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc. The best of the best: the portal for top lists & rankings: Strategy and business building for the data-driven economy: Pharmaceutical market: worldwide revenue 2001-2022, Global pharmaceutical market - revenue distribution 2010-2021, by region, Top therapeutic classes by global pharmaceutical sales 2018 estimates, Total global pharmaceutical R&D spending 2014-2028, Number of novel drugs approved annually by CDER 2008-2022, Revenue of the worldwide pharmaceutical market from 2001 to 2022 (in billion U.S. dollars), World pharmaceutical sales 2017-2021 by region, Global pharmaceutical sales from 2017 to 2021, by region* (in billion U.S. dollars), World pharmaceutical market distribution by submarket 2014-2021, Distribution of the total global pharmaceutical market sales from 2014 to 2021, by submarket*, Revenues of top 10 global pharmaceutical markets 2021, Revenues of top 10 national pharmaceutical markets worldwide in 2021 (in billion U.S. dollars), Top pharmaceutical products by sales worldwide 2021, Leading pharmaceutical products by sales worldwide in 2021 (in billion U.S. dollars), Share of pharmaceutical value worldwide 2021, by country, Value share of the pharmaceutical market worldwide as of November 2021, by country*, Value share of pharmaceutical subsectors worldwide 2003 vs. 2021, Value share of the pharmaceutical market worldwide in 2003 and 2021, by subsector*, Top therapy classes by spending global market 2026 forecast, Projected top therapy areas worldwide in 2026, by spending (in billion U.S. dollars), Global pharmaceutical revenue by technology 2012-2026, Global pharmaceutical revenue distributed by technology from 2012 to 2026 (in billion U.S. dollars), Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026, Prescription drugs sales worldwide excluding generics and orphan drugs from 2012 to 2026 (in billion U.S. dollars), Projection of global revenue for orphan prescription drugs 2012-2026, Global prescription orphan drug sales from 2012 to 2026 (in billion U.S. dollars), Worldwide generic prescription drug sales 2012-2026, Worldwide generic prescription drug sales from 2012 to 2026 (in billion U.S. dollars), Revenue of the global OTC pharmaceutical market 2016-2027, Revenue of the global OTC pharmaceutical market from 2016 to 2027 (in billion U.S. dollars), Global oncology spending from 2011 to 2023 (in billion U.S. dollars), Tota pharmaceutical value worldwide 2021, by subsector, Total pharmaceutical value worldwide as of November 2021, by subsector* (in million U.S. dollars), Top 50 pharmaceutical companies - Rx sales and R&D spending 2021, Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2021 (in billion U.S. dollars), Global Rx drug market share by top companies 2019 and 2026, Top 20 pharmaceutical companies worldwide based on prescription drug market share in 2019 and 2026*, Top 10 biotech and pharmaceutical companies based on market cap 2022, Leading 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2022 (in billion U.S. dollars), Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars), Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars), Total sales of the Roche Group from 2006 to 2022 (in million Swiss francs), Johnson & Johnson's total sales 2005-2022, Johnson & Johnson's total sales from 2005 to 2022 (in million U.S. dollars), Projected top pharmaceutical companies based on new sales 2023, Leading pharmaceutical companies worldwide based on projected sales increase during 2023 (in billion U.S. dollars), Total global spending on pharmaceutical research and development from 2014 to 2028 (in billion U.S. dollars), Global top pharmaceutical companies based on R&D spending 2026, Global top 10 pharmaceutical companies based on projected R&D spending in 2026 (in billion U.S. dollars), Patent expiration risks for total worldwide prescription drug revenue 2020-2028, Worldwide total prescription drug revenue at risk from patent expiration from 2020 to 2028 (in billion U.S. dollars), Worldwide prescription drug revenue - market risk from patent expiration 2020-2028, Share of global prescription drug revenue at risk from patent expiration from 2020 to 2028, Pharmaceutical industry - number of new substances 1998-2021, Number of new chemical or biological entities developed between 1998 and 2021, by region of origin, Pharma companies worldwide with active R&D pipelines 2001-2022, Total number of pharmaceutical companies with active R&D pipelines worldwide from 2001 to 2022, Total number of novel drugs approved by CDER from 2008 to 2022, Projected most valuable R&D projects based on net present value 2022, Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2022 (in billion U.S. dollars), World pharmaceutical sales by region forecast 2025, Projected global pharmaceutical sales for 2025, by region* (in billion U.S. dollars), Global spending on medicines in 2010, 2021, and a forecast for 2026 (in billion U.S. dollars), CAGR by product type in pharmaceutical markets forecast 2022-2026, Projected pharmaceutical spending CAGR worldwide between 2022 and 2026, by market and product type, Country comparison in spending on medicine 2026, Projected spending on medicine of selected countries worldwide in 2026 (in billion U.S. dollars), Leading global pharmaceutical products by projected sales 2026, Projected top 10 global pharmaceutical products by sales in 2026 (in million U.S. dollars), Top global biopharma drugs by lifetime sales up to 2026, Projected top 10 pharmaceutical products worldwide based on lifetime sales as of 2026 (in billion U.S. dollars), COVID-19 vaccine dose numbers by top manufacturer 2021, Drug manufacturers with the highest number of ordered COVID-19 vaccine doses as of March 2021* (in million doses), Top companies by COVID-19 treatment vaccines in development June 2022, Leading companies by number of COVID-19 drugs and vaccines in development as of June 3, 2022, Number of COVID-19 drugs in development worldwide by phase June 2022, Number of coronavirus (COVID-19) drugs and vaccines in development worldwide as of June 3, 2022, by phase, BARDA funding for the development of COVID-19 vaccines in the U.S. 2021, BARDA funding for the development of COVID-19 vaccines in the United States as of March 2021* (in million U.S. dollars), Forecasted sales of select COVID-19 vaccines worldwide 2021-2022, Forecasted sales of select COVID-19 vaccines worldwide in 2021 and 2022 (in billion U.S. dollars), Gilead Science's remdesivir manufacturing projections 2020, Cumulative amount of remdesivir treatment courses projected to be manufactured by Gilead Sciences during 2020 (in 1,000s), Global mRNA vaccines and therapeutics market for COVID-19 Q4 2020 vs. 2025, Global mRNA vaccines and therapeutics market for COVID-19 in Q4 2020 and a forecast for Q4 2025 (in million U.S. dollars).